Balyasny Asset Management LLC Sangamo Therapeutics, Inc Transaction History

Balyasny Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $11,438 - $20,652	31,773 New	31,773 $11,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $59,153 - $108,269	21,355 New	21,355 $67,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $25,429 - $48,146	7,753 Added 42.72%	25,900 $107,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $94,908 - $141,909	18,147 New	18,147 $105,000
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $577,492 - $1.1 Million	-92,994 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $261,908 - $458,987	51,863 Added 126.09%	92,994 $592,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $330,281 - $481,232	41,131 New	41,131 $344,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $156,239 - $210,966	-17,264 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $151,060 - $224,949	17,264 New	17,264 $186,000
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $199,222 - $330,574	-25,806 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $245,415 - $428,379	25,806 New	25,806 $296,000
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $167,631 - $250,724	-14,451 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $121,388 - $216,765	14,451	14,451 $217,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.